 Hanan Elajaili
Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electron Spin Resonance Spectroscopy | 18 | 2023 | 86 | 3.170 |
Why?
| | Nitrogen Oxides | 9 | 2023 | 47 | 1.500 |
Why?
| | Superoxides | 3 | 2023 | 214 | 1.010 |
Why?
| | Oxidation-Reduction | 6 | 2023 | 926 | 1.010 |
Why?
| | Quinones | 2 | 2015 | 10 | 0.990 |
Why?
| | Acute Lung Injury | 3 | 2023 | 300 | 0.980 |
Why?
| | Hydroxylamine | 1 | 2023 | 8 | 0.900 |
Why?
| | Reactive Oxygen Species | 4 | 2023 | 536 | 0.870 |
Why?
| | Superoxide Dismutase | 2 | 2023 | 305 | 0.800 |
Why?
| | Mice, Inbred C57BL | 4 | 2023 | 4718 | 0.690 |
Why?
| | Lung | 7 | 2023 | 3595 | 0.670 |
Why?
| | Electrons | 2 | 2014 | 72 | 0.580 |
Why?
| | Nails | 1 | 2016 | 8 | 0.550 |
Why?
| | Radiometry | 1 | 2016 | 42 | 0.540 |
Why?
| | Temperature | 1 | 2019 | 578 | 0.530 |
Why?
| | Biological Assay | 1 | 2016 | 113 | 0.530 |
Why?
| | Disease Models, Animal | 3 | 2023 | 3545 | 0.500 |
Why?
| | Disulfides | 1 | 2015 | 90 | 0.500 |
Why?
| | Alcohols | 1 | 2014 | 28 | 0.470 |
Why?
| | Sulfhydryl Compounds | 1 | 2015 | 177 | 0.440 |
Why?
| | Bleomycin | 2 | 2021 | 228 | 0.310 |
Why?
| | Mice | 9 | 2023 | 14927 | 0.280 |
Why?
| | Free Radicals | 3 | 2015 | 99 | 0.270 |
Why?
| | Oxidative Stress | 3 | 2022 | 1085 | 0.260 |
Why?
| | Cerium | 2 | 2021 | 13 | 0.240 |
Why?
| | Mitochondria | 2 | 2020 | 750 | 0.230 |
Why?
| | Oxygen | 4 | 2016 | 854 | 0.220 |
Why?
| | Animals | 10 | 2023 | 31867 | 0.210 |
Why?
| | Uncoupling Protein 2 | 1 | 2022 | 8 | 0.210 |
Why?
| | Antimycin A | 2 | 2020 | 13 | 0.210 |
Why?
| | Deuterium | 4 | 2014 | 79 | 0.190 |
Why?
| | Myofibroblasts | 1 | 2022 | 116 | 0.190 |
Why?
| | Succinate Dehydrogenase | 1 | 2021 | 42 | 0.190 |
Why?
| | Phantoms, Imaging | 3 | 2016 | 137 | 0.180 |
Why?
| | Catechin | 1 | 2020 | 23 | 0.170 |
Why?
| | Lipopolysaccharides | 1 | 2023 | 817 | 0.170 |
Why?
| | Mice, Knockout | 2 | 2023 | 2585 | 0.170 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 20 | 0.170 |
Why?
| | Reperfusion Injury | 1 | 2022 | 254 | 0.170 |
Why?
| | Lung Injury | 1 | 2021 | 198 | 0.160 |
Why?
| | Algorithms | 3 | 2015 | 1489 | 0.160 |
Why?
| | Cell Compartmentation | 1 | 2019 | 52 | 0.160 |
Why?
| | RAW 264.7 Cells | 1 | 2019 | 41 | 0.160 |
Why?
| | Glioma | 1 | 2022 | 296 | 0.160 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2019 | 71 | 0.160 |
Why?
| | Equipment Failure Analysis | 2 | 2016 | 135 | 0.160 |
Why?
| | Electromagnetic Fields | 2 | 2015 | 22 | 0.160 |
Why?
| | Spin Labels | 3 | 2014 | 48 | 0.160 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 296 | 0.150 |
Why?
| | Hyaluronic Acid | 1 | 2020 | 189 | 0.150 |
Why?
| | Nanoparticles | 1 | 2021 | 313 | 0.150 |
Why?
| | Equipment Design | 2 | 2016 | 513 | 0.140 |
Why?
| | Sensitivity and Specificity | 3 | 2016 | 1715 | 0.140 |
Why?
| | Molecular Structure | 2 | 2017 | 438 | 0.140 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2016 | 512 | 0.140 |
Why?
| | Carboxylic Acids | 1 | 2017 | 26 | 0.140 |
Why?
| | Triacetoneamine-N-Oxyl | 2 | 2014 | 2 | 0.140 |
Why?
| | Microwaves | 1 | 2016 | 31 | 0.130 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2019 | 590 | 0.130 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2022 | 510 | 0.130 |
Why?
| | Cattle | 1 | 2019 | 924 | 0.130 |
Why?
| | Pyrroles | 1 | 2017 | 181 | 0.130 |
Why?
| | Pneumonia | 1 | 2021 | 568 | 0.130 |
Why?
| | Antioxidants | 1 | 2019 | 530 | 0.130 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2014 | 482 | 0.120 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 638 | 0.120 |
Why?
| | Protons | 1 | 2015 | 80 | 0.120 |
Why?
| | Spin Trapping | 1 | 2014 | 3 | 0.120 |
Why?
| | Kidney | 1 | 2022 | 1186 | 0.120 |
Why?
| | MicroRNAs | 1 | 2021 | 603 | 0.120 |
Why?
| | Methanol | 1 | 2014 | 29 | 0.120 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1036 | 0.120 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2015 | 137 | 0.120 |
Why?
| | Reproducibility of Results | 3 | 2016 | 2799 | 0.120 |
Why?
| | Hydrogen Bonding | 1 | 2014 | 143 | 0.120 |
Why?
| | Hydroxyl Radical | 1 | 2014 | 89 | 0.120 |
Why?
| | Magnetics | 1 | 2014 | 39 | 0.110 |
Why?
| | Transducers | 1 | 2014 | 25 | 0.110 |
Why?
| | Glutathione | 1 | 2015 | 302 | 0.110 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 850 | 0.110 |
Why?
| | Molecular Imaging | 1 | 2014 | 50 | 0.110 |
Why?
| | Hypoxia | 1 | 2020 | 959 | 0.110 |
Why?
| | Models, Biological | 1 | 2020 | 1636 | 0.110 |
Why?
| | Indicators and Reagents | 4 | 2014 | 99 | 0.110 |
Why?
| | Male | 5 | 2023 | 55735 | 0.100 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 1879 | 0.100 |
Why?
| | Ethanol | 1 | 2014 | 548 | 0.090 |
Why?
| | Nitrogen Radioisotopes | 3 | 2014 | 6 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2020 | 1736 | 0.080 |
Why?
| | Anisotropy | 3 | 2013 | 62 | 0.080 |
Why?
| | Signal Transduction | 2 | 2020 | 4525 | 0.070 |
Why?
| | HIV Infections | 1 | 2019 | 2470 | 0.060 |
Why?
| | Time Factors | 1 | 2014 | 6141 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3118 | 0.060 |
Why?
| | Nitrogen Isotopes | 2 | 2013 | 55 | 0.050 |
Why?
| | Humans | 8 | 2022 | 115047 | 0.050 |
Why?
| | Radiation, Ionizing | 1 | 2022 | 72 | 0.050 |
Why?
| | Solutions | 2 | 2012 | 148 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 213 | 0.050 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2022 | 171 | 0.050 |
Why?
| | Time-to-Treatment | 1 | 2021 | 147 | 0.040 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2020 | 42 | 0.040 |
Why?
| | Cell Respiration | 1 | 2020 | 74 | 0.040 |
Why?
| | Electron Transport Complex I | 1 | 2020 | 33 | 0.040 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2020 | 8 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 454 | 0.040 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 89 | 0.040 |
Why?
| | Antioxidant Response Elements | 1 | 2019 | 5 | 0.040 |
Why?
| | Sirtuin 3 | 1 | 2020 | 52 | 0.040 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2019 | 11 | 0.040 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2020 | 184 | 0.040 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2019 | 31 | 0.040 |
Why?
| | Heme Oxygenase-1 | 1 | 2019 | 52 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 220 | 0.040 |
Why?
| | Sulfonamides | 1 | 2022 | 445 | 0.040 |
Why?
| | Water | 2 | 2012 | 409 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2022 | 604 | 0.040 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 374 | 0.040 |
Why?
| | Protein Kinases | 1 | 2020 | 307 | 0.040 |
Why?
| | HIV | 1 | 2019 | 208 | 0.040 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2020 | 236 | 0.040 |
Why?
| | Fibroblasts | 1 | 2022 | 839 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2019 | 541 | 0.040 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2022 | 856 | 0.040 |
Why?
| | Up-Regulation | 1 | 2020 | 812 | 0.030 |
Why?
| | Radionuclide Imaging | 1 | 2016 | 115 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 1721 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 1955 | 0.030 |
Why?
| | Blood Pressure | 1 | 2022 | 1539 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2022 | 2715 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2017 | 405 | 0.030 |
Why?
| | Signal-To-Noise Ratio | 1 | 2015 | 57 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 900 | 0.030 |
Why?
| | Cyclic N-Oxides | 1 | 2014 | 30 | 0.030 |
Why?
| | Muramidase | 1 | 2014 | 72 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2019 | 685 | 0.030 |
Why?
| | Pulmonary Artery | 1 | 2020 | 1028 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2645 | 0.030 |
Why?
| | Viscosity | 1 | 2013 | 82 | 0.030 |
Why?
| | Apoptosis | 1 | 2022 | 2366 | 0.030 |
Why?
| | Solvents | 1 | 2013 | 104 | 0.030 |
Why?
| | Image Enhancement | 1 | 2014 | 181 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2020 | 2191 | 0.030 |
Why?
| | Models, Molecular | 1 | 2017 | 1379 | 0.020 |
Why?
| | Isotope Labeling | 1 | 2011 | 69 | 0.020 |
Why?
| | Inflammation | 1 | 2021 | 2485 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 698 | 0.020 |
Why?
| | Models, Statistical | 1 | 2013 | 602 | 0.020 |
Why?
| | Female | 2 | 2022 | 59617 | 0.010 |
Why?
| | Aged | 1 | 2022 | 19122 | 0.010 |
Why?
|
|
Elajaili's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|